30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

CervoMed Inc (CRVO)

Track

Recent insider activity at CervoMed Inc. shows a significant buy transaction of nearly $3 million by Joshua S. Boger on June 11, 2026. Prior to this, in November 2025, several executives including the CEO and CFO made multiple smaller buy transactions. The company's stock has experienced a substantial decline of over 41% in the last 90 days.
Stock chart
Ticker: CRVO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BOGER JOSHUA S
1 purchase — total 100,000 USD
Buy 11 Jun 2026
Value US$2,145,394.70 | Price 314.14 | Shares 91,540
Buy 18 Nov 2025
Value US$4,245,345.19 | Price 269.81 | Shares 78,484
Buy 18 Nov 2025
Value US$20,800.00 | Price 8.32 | Shares 2,500
Buy 17 Nov 2025
Value US$91,308.78 | Price 8.46 | Shares 10,793
Buy 17 Nov 2025
Value US$91,427.22 | Price 8.46 | Shares 10,807
Buy 17 Nov 2025
Value US$29,505.00 | Price 8.43 | Shares 3,500
Buy 17 Nov 2025
Value US$8,450.00 | Price 8.45 | Shares 1,000
Buy 17 Nov 2025
Value US$91,427.22 | Price 8.46 | Shares 10,807
Buy 17 Nov 2025
Value US$91,308.78 | Price 8.46 | Shares 10,793
Buy 14 Nov 2025
Value US$75,700.00 | Price 7.57 | Shares 10,000
Buy 14 Nov 2025
Value US$12,782.15 | Price 7.55 | Shares 1,693
Buy 14 Nov 2025
Value US$12,921.99 | Price 7.57 | Shares 1,707
Buy 14 Nov 2025
Value US$12,921.99 | Price 7.57 | Shares 1,707
Buy 14 Nov 2025
Value US$12,782.15 | Price 7.55 | Shares 1,693
Buy 13 Nov 2025
Value US$33,396.97 | Price 7.51 | Shares 4,447
Buy 13 Nov 2025
Value US$33,396.97 | Price 7.51 | Shares 4,447
Buy 12 Nov 2025
Value US$40,814.55 | Price 7.35 | Shares 5,553
Buy 12 Nov 2025
Value US$26,040.00 | Price 7.44 | Shares 3,500
Buy 12 Nov 2025
Value US$40,814.55 | Price 7.35 | Shares 5,553
Buy 14 May 2025
Value US$35,811.18 | Price 8.46 | Shares 4,233
Buy 27 Aug 2024
Value US$18,160.00 | Price 18.16 | Shares 1,000
Sale 26 Feb 2024
Value US$0.00 | Price 0.00 | Shares 36
Buy 13 May 2021
Value US$19,999.46 | Price 0.61 | Shares 32,786
Buy 17 Nov 2020
Value US$3,150.00 | Price 0.63 | Shares 5,000
Buy 16 Nov 2020
Value US$6,700.00 | Price 0.67 | Shares 10,000
Buy 16 Nov 2020
Value US$9,240.00 | Price 0.66 | Shares 14,000
Buy 28 Dec 2016
Value US$0.00 | Price 0.00 | Shares 290,580
Buy 15 Dec 2016
Value US$0.00 | Price 0.00 | Shares 512,109
Buy 2 May 2013
Value US$1,100,000.04 | Price 0.06 | Shares 18,333,334
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-11 B Purchase
BOGER JOSHUA S
Non-Executive Director Large shareholder
91,540 +39.9%
314.14
US$2,145,395 		91,540 +39.9% 314.14 US$2,145,395
2025-11-19 2025-11-18 B Purchase
1.5
Winton Matthew

Chief Commercial and Business

Officer
78,484 -23.8%
269.81
US$4,245,345 		78,484 -23.8% 269.81 US$4,245,345
2025-11-19 2025-11-18 B Purchase
2.2
ELDER WILLIAM ROBERT

CFO, GC & Secretary

Officer
55,091 +8.1%
193.43
US$2,690,627 		55,091 +8.1% 193.43 US$2,690,627
2025-11-19 2025-11-17 B Purchase
1.3
ALAM JOHN J

CEO & President

Executive Director Large shareholder
10,793 +632.3%
8.46
US$91,309 		10,793 +632.3% 8.46 US$91,309
2025-11-19 2025-11-17 B Purchase
1.3
ALAM JOHN J

CEO & President

Executive Director Large shareholder
10,807 +0.7%
8.46
US$91,427 		10,807 +0.7% 8.46 US$91,427
2025-11-19 2025-11-17 B Purchase
1.5
Winton Matthew

Chief Commercial and Business

Officer
3,500 +35.0%
8.43
US$29,505 		3,500 +35.0% 8.43 US$29,505
2025-11-19 2025-11-17 B Purchase
2.2
ELDER WILLIAM ROBERT

CFO, GC & Secretary

Officer
1,000 +11.1%
8.45
US$8,450 		1,000 +11.1% 8.45 US$8,450
2025-11-19 2025-11-17 B Purchase
1.4
Gregoire Sylvie
Non-Executive Director Large shareholder
10,807 +638.3%
8.46
US$91,427 		10,807 +638.3% 8.46 US$91,427
2025-11-19 2025-11-17 B Purchase
1.4
Gregoire Sylvie
Non-Executive Director Large shareholder
10,793 +0.7%
8.46
US$91,309 		10,793 +0.7% 8.46 US$91,309
2025-11-17 2025-11-14 B Purchase
1.5
Winton Matthew

Chief Commercial and Business

Officer
10,000 +inf%
7.57
US$75,700 		10,000 +inf% 7.57 US$75,700
2025-11-17 2025-11-14 B Purchase
1.4
Gregoire Sylvie
Non-Executive Director Large shareholder
1,693 +inf%
7.55
US$12,782 		1,693 +inf% 7.55 US$12,782
2025-11-17 2025-11-14 B Purchase
1.4
Gregoire Sylvie
Non-Executive Director Large shareholder
1,707 +0.1%
7.57
US$12,922 		1,707 +0.1% 7.57 US$12,922
2025-11-17 2025-11-14 B Purchase
1.3
ALAM JOHN J

CEO & President

Executive Director Large shareholder
1,707 +inf%
7.57
US$12,922 		1,707 +inf% 7.57 US$12,922
2025-11-17 2025-11-14 B Purchase
1.3
ALAM JOHN J

CEO & President

Executive Director Large shareholder
1,693 +0.1%
7.55
US$12,782 		1,693 +0.1% 7.55 US$12,782
2025-11-17 2025-11-13 B Purchase
1.4
Gregoire Sylvie
Non-Executive Director Large shareholder
4,447 +0.3%
7.51
US$33,397 		4,447 +0.3% 7.51 US$33,397
2025-11-17 2025-11-13 B Purchase
1.3
ALAM JOHN J

CEO & President

Executive Director Large shareholder
4,447 +0.3%
7.51
US$33,397 		4,447 +0.3% 7.51 US$33,397
2025-11-13 2025-11-12 B Purchase
1.3
ALAM JOHN J

CEO & President

Executive Director Large shareholder
5,553 +0.4%
7.35
US$40,815 		5,553 +0.4% 7.35 US$40,815
2025-11-13 2025-11-12 B Purchase
2.2
ELDER WILLIAM ROBERT

CFO, GC & Secretary

Officer
3,500 +63.6%
7.44
US$26,040 		3,500 +63.6% 7.44 US$26,040
2025-11-13 2025-11-12 B Purchase
1.4
Gregoire Sylvie
Non-Executive Director Large shareholder
5,553 +0.4%
7.35
US$40,815 		5,553 +0.4% 7.35 US$40,815
2025-05-14 2025-05-14 B Purchase
2.2
ELDER WILLIAM ROBERT

CFO, GC & Secretary

Officer
4,233 +334.1%
8.46
US$35,811 		4,233 +334.1% 8.46 US$35,811
2024-08-27 2024-08-27 B Purchase
2.2
ELDER WILLIAM ROBERT

CFO & GC

Officer
1,000 +374.5%
18.16
US$18,160 		1,000 +374.5% 18.16 US$18,160
2024-02-28 2024-02-26 S Sale
BOGER JOSHUA S
Non-Executive Director Large shareholder
36
0.00
US$0 		36 0.00 US$0
2021-05-17 2021-05-13 B Purchase
1.7
Hollingsworth Jane H
Non-Executive Director
32,786 +inf%
0.61
US$19,999 		32,786 +inf% 0.61 US$19,999
2020-11-18 2020-11-17 B Purchase
2.2
ELDER WILLIAM ROBERT

GC & Secretary

Officer
5,000 +50.0%
0.63
US$3,150 		5,000 +50.0% 0.63 US$3,150
2020-11-18 2020-11-16 B Purchase
2.2
ELDER WILLIAM ROBERT

GC & Secretary

Officer
10,000 +inf%
0.67
US$6,700 		10,000 +inf% 0.67 US$6,700
2020-11-18 2020-11-16 B Purchase
3.2
Cobuzzi Robert Joseph Jr.

President & CEO

Executive Director
14,000 +inf%
0.66
US$9,240 		14,000 +inf% 0.66 US$9,240
2016-12-28 2016-12-28 B Purchase Giles Mark T Non-Executive Director
290,580
0.00
US$0 		290,580 0.00 US$0
2016-12-16 2016-12-15 B Purchase Giles Mark T Non-Executive Director
512,109
0.00
US$0 		512,109 0.00 US$0
2013-06-10 2013-05-02 B Purchase BLECH ISAAC Large shareholder
18,333,334 +inf%
0.06
US$1,100,000 		18,333,334 +inf% 0.06 US$1,100,000
Explore more

More insider trading research around CervoMed Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America